Browsing by Titles

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 2 of 2

Article
A Nonrandomized Phase 2 Trial of EG-Mirotin, a Novel, First-in-Class, Subcutaneously Deliverable Peptide Drug for Nonproliferative Diabetic Retinopathy
  • Yoo, Seunghoon ; 
  • You, Dae Hyuk ; 
  • Lee, Jeongyoon ; 
  • Hong, H. Christian ; 
  • Lee, Sung Jin
  • 2023-01
  • Yoo, Seunghoon. (2023-01). A Nonrandomized Phase 2 Trial of EG-Mirotin, a Novel, First-in-Class, Subcutaneously Deliverable Peptide Drug for Nonproliferative Diabetic Retinopathy. Medicina, 59(1). doi: 10.3390/medicina59010178
  • MDPI
  • View : 183
  • Download : 0
Article
Interleukin-5 suppresses Vascular Endothelial Growth Factor-induced angiogenesis through STAT5 signaling
  • 2018-10
  • Bucher, Felicitas. (2018-10). Interleukin-5 suppresses Vascular Endothelial Growth Factor-induced angiogenesis through STAT5 signaling. doi: 10.1016/j.cyto.2018.06.021
  • Academic Press
  • View : 1044
  • Download : 0
1